The growing demand for synthetic oligonucleotides in precision medicine has intensified the need for efficient, scalable purification methods that can handle complex modified sequences while maintaining high purity standards.
Traditional ion-pair reversed-phase methods, while effective, often require expensive volatile additives and organic solvents that create environmental concerns and add significant operational costs to production workflows.
This application note presents a proven anion-exchange chromatography approach that delivers exceptional purification performance using standard aqueous buffers, enabling labs to achieve superior results while reducing costs and environmental impact.
Download this application note to discover:
- How to achieve greater purity using cost-effective aqueous buffer systems
- A validated scale-up strategy for transitioning from analytical to preparative oligonucleotide purification
- Optimized fraction collection and analysis workflows to maximize yield
Application Note
Biopharma/Pharma
Authors
Andrea Angelo P. Tripodi and
Andrew Coffey
Agilent Technologies, Inc.
Abstract
Ion-exchange chromatography (IEX) is an effective method for separating and
purifying oligonucleotides based on their charge. Given their negatively charged
phosphate backbone, anion-exchange chromatography (AEX) is the preferred
approach. While ion-pair reversed-phase chromatography (IP-RP) is commonly used
for oligonucleotide analysis, IEX offers distinct advantages for specific applications,
providing robustness and compatibility with standard buffers across both analytical
and preparative scales. This application note highlights the excellent performance
of Agilent PL-SAX columns for synthetic oligonucleotide analysis and suggests an
optimal kickoff for exploring alternative method conditions.
Scalable Purification of a
Synthetic Oligonucleotide Using
Agilent PL-SAX Columns
2
Columns
Analytical columns:
Agilent PL-SAX 1000Å HPLC column, 4.6 × 150 mm, 8 µm
(part number PL1551-3802)
Agilent AdvanceBio oligonucleotide, 4.6 × 150 mm, 2.7 µm
(part number 653950-702)
Preparative column:
Agilent PL-SAX 1000Å, 25 × 150 mm, 10 µm
(part number PL1251-3102)
Sample
The sample to be purified was a crude all-2'-O-methylated
22-mer oligonucleotide provided by a customer.
Sample preparation
The RNA sample was diluted in mobile phase A containing
10 mM Tris HCl pH 8.0. The concentration for the analytical
run was 1 mg/mL, and 20 mg/mL for the preparative run.
Software and data processing
Agilent OpenLab software suite, version 2.8.
Reagents and chemicals
All reagents were HPLC grade or higher.
Method parameters
Parameter Value
Column Agilent PL-SAX 1000Å, 4.6 × 150 mm, 8 µm
Eluent A 10 mM tris buffer pH 8.0
Eluent B 10 mM tris buffer + 1 M NaCl
Gradient 20 to 80% B in 30 minutes
Flow Rate 1.0 mL/min
Column Temperature 6 °C
Detection (DAD) 260 nm
Injection Volume 10 µL
Table 1. Analytical LC parameters for the analysis of the crude sample.
Parameter Value
Column Agilent PL-SAX 1000Å, 25 × 150 mm, 10 µm
Eluent A 10 mM tris buffer pH 8.0
Eluent B 10 mM tris buffer + 1 M NaCl
Gradient 20 to 100% B in 27 minutes
Flow Rate 29.5 mL/min
Column Temperature 25 °C
Detection (DAD) 260 nm
Injection Volume 300 and 800 µL
Table 2. Preparative LC parameters for the purification of the crude sample.
Introduction
Synthetic oligonucleotides have gained significant attention in
recent years due to their ability to regulate protein expression
and enable gene editing. Advances in synthetic methods
have led to greater accuracy and improved efficiency in
oligonucleotide production. However, the inherent complexity
and extensive modifications of these molecules can often
result in significant variability in yield and purity. Choosing
the appropriate column chemistry for purification depends
on factors such as desired final purity, buffer compatibility,
and production scale. AEX is widely used for purifying
oligonucleotides, from short sequences to large molecules
up to 100 mer in length.1,2 A key advantage of AEX is its
compatibility with commonly available buffers, such as tris,
phosphate, or ammonium salts, rather than volatile additives
such as hexafluoroisopropanol (HFIP), typically required
for IP-RP. HFIP is costly and toxic for the environment. In
addition, IP-RP often requires the use of organic solvents, like
acetonitrile (ACN) or methanol, which are harmful and more
expensive than aqueous, salt-based buffers. Moreover, IP-RP
leaves the purified oligonucleotide with the residual ion-pair
counter ion requiring further cleanup. This makes AEX a
highly cost-effective and practical technique for separating
oligonucleotides from related impurities.
Experimental
Analytical equipment
An Agilent 1290 Infinity III LC system was composed of the
following modules:
– Agilent 1290 Infinity III high-speed pump (G7120A)
– Agilent Infinity III multisampler with sample thermostat
(G7167B)
– Agilent 1290 Infinity III multicolumn thermostat (G7116A)
– Agilent 1290 Infinity III diode array detector (G7165A)
with a 10 mm InfinityLab Max-Light cartridge cell
(G7117-60020)
Preparative equipment
An Agilent 1290 Infinity II preparative LC system was
composed of the following modules:
– Agilent 1290 Infinity II preparative binary pump (G7161B)
– Agilent 1260 Infinity II preparative fraction collector
(G7157A)
– Agilent 1290 Infinity II preparative column compartment
(G7163B)
– Agilent 1260 Infinity II diode array detector (G7165A)
3
Parameter Value
Column Agilent AdvanceBio oligonucleotide, 4.6 × 150 mm, 2.7 µm
Eluent A 100 mL 1 M TEAA pH 8.65 + 900 mL water
Eluent B 100 mL 1 M TEAA pH 8.65 + 900 mL ACN
Gradient 5 to 22% B in 20 minutes
Flow Rate 1.0 mL/min
Column Temperature 60 °C
Detection (DAD) 260/4 nm (reference 360/20 nm) peak width > 0.025 min
(10 Hz)
Injection Volume 5.0 µL
Table 3. Analytical LC parameters for fraction re-analysis.
Results and discussion
The separation and purification of a 22-mer synthetic
oligonucleotide can be easily achieved using a PL-SAX
column. The fractions that are obtained through IEX can
be easily analyzed by IP-RP using 0.1 M TEAA with an
AdvanceBio oligonucleotide column. The results demonstrate
the performance of the PL-SAX 1000Å, 4.6 mm id, 8 µm for
the analysis of the crude sample before purification (Figure 1).
An analytical PL-SAX 1000Å, 4.6 × 150 mm, 8 μm column
was used, containing stationary phase media with the same
specifications as the preparative 150 × 25 mm column.
An initial scouting gradient was used, from 20 to 80% B over
30 minutes, to ensure that adequate separation of the main
peak from the impurities was achieved (Table 1).
A second gradient from 40 to 80% B over 20 minutes,
using the same 2% B per minute gradient did not offer
any improvement. Integration of this analytical separation
suggests that the purity of the crude sample was
approximately 85%. For the preparative scale separation,
the same mobile phase composition was used, allowing
for the column to be flushed with up to 1 M NaCl at the end
of each run. This can help to ensure that no later-eluting
impurities are allowed to build up on the column. The flow
rate was scaled up linearly from 1.0 mL/min on the 4.6 mm
id column to 29.5 mL/min on the 25 mm id column. Two
runs were made (see Tables 1 and 2 for conditions). The
first run used an injection volume of 300 µL of 20 mg/mL
crude oligonucleotide solution (equating to 6 mg injected)
to ensure that the detector was not saturated, and that the
separation efficiency could be determined (Figure 2). After
demonstrating an equal separation performance to the one
seen on the analytical column, a larger 800 µL injection was
made (equating to 16 mg injected), as shown in Figure 3.
Notice that the main peak has now saturated the detector.
There is also a slight shift in retention time due to the amount
of material loaded onto the column.
Figure 1. Analytical LC/UV analysis of the 22-mer crude synthetic oligonucleotide. LC gradient and temperature 40 to 80% B, 0 to 20 minutes (2% B per minute) at
60 °C (Table 1).
1 2 3 4 5678 9 10 11 12 13 14 15 16 17 18 19
Retention time (min)
×102
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
Response (mAU)
4
Figure 3. Preparative LC/UV separation of the 22-mer crude synthetic oligonucleotide, 800 µL injection (20 mg/mL). LC gradient and temperature 20 to 100% B,
0 to 27 minutes; 25 °C (Table 2).
Figure 2. Preparative LC/UV separation of the 22-mer crude synthetic oligonucleotide, 300 µL injection (20 mg/mL). LC gradient and temperature 20 to 100% B,
0 to 27 minutes; 25 °C (Table 2).
1 2 345678 9 10 11 12 13 14 15 16 17 18 19 20
Retention time (min)
×103
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
2.6
2.8
Response (mAU)
1 2 3 4 5678 9 10 11 12 13 14 15 16 17 18 19 20
Retention time (min)
×103
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
2.6
2.8
Response (mAU)
5
The dynamic binding capacity for the PL-SAX 8 µm 1000Å
is approximately 12 mg per mL of column volume. A
150 × 25 mm column has a volume of 74 mL and so an
overall capacity (to saturation) of about 880 mg. A 16 mg
injection therefore equates to almost 2% of the binding
capacity, which is an ideal amount to ensure there is minimal
risk of overloading the column causing impurities to coelute
with the main peak. Of course, it is possible to further
optimize the separation to maximize the amount of crude
sample that can be injected per run. The fraction collector
was set to conservatively collect 1.5 mL volume fractions.
This was to ensure that closely eluting impurities that may
partially coelute with the main peak could be removed if
necessary. After collecting 16 fractions as shown in Figure 4,
each fraction was analyzed by IP-RP (see Table 3 for
the method).
Figure 4. Analytical LC-UV chromatograms (260 nm) showing the main fractions collected from the fraction collector.
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 02
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 01
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 03
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 04
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 05
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 06
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 07
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 08
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 09
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 10
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 11
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 12
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 13
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 14
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 15
×103
2468 10 12 14 16 18 20
Retention time (min)
0
1
Response
(mAU)
Fraction 16
×103
6
By assessing the yield and purity of each fraction it is possible
to calculate which fractions should be combined to give the
overall best yield and purity (Table 4).
Figure 5 shows an offset overlay of the chromatogram
of each fraction. The first two or three fractions contain a
small amount of an earlier eluting component as well as the
main peak.
Fraction Main Peak Area Impurity Area Total Area
Main Peak Area
Percentage
F01 1,267.9 151.8 1,419.7 89%
F02 1,909.1 131.4 2,040.5 94%
F03 2,142.3 109.9 2,252.2 95%
F04 2,243.4 89.1 2,332.5 96%
F05 2,194.8 75.1 2,269.9 97%
F06 2,082.3 67.5 2,149.8 97%
F07 1,925.2 59.7 1,984.9 97%
F08 1,732.8 49.4 1,782.1 97%
F09 1,546.4 45.7 1,592.1 97%
F10 1,353.4 41.9 1,395.3 97%
F11 1,159.1 38.8 1,197.9 97%
F12 977.6 45.0 1,022.6 96%
F13 803.5 40.9 844.4 95%
F14 635.8 32.8 668.5 95%
F15 489.9 28.1 517.9 95%
F16 373.0 27.9 400.9 93%
22,836.5 1,034.9 23,871.4 96%
Table 4. Peak area and product purity of fractions for the main peak by IP-RP.
Figure 5. Offset, overlaid chromatograms of Figure 4 (UV 260 nm) of the IP-RP analysis of sixteen fractions. See Table 2 for LC gradient and temperature.
Retention time
Response
F01
F02
F03
F04 F05 F06
F07
F08
F09
F10
F12
F11
F13
F14
F15 F16
www.agilent.com
DE-006667
This information is subject to change without notice.
© Agilent Technologies, Inc. 2025
Printed in the USA, May 22, 2025
5994-8381EN
Conclusion
This application note demonstrates optimized method
conditions for the purification of an RNA sample using
anion-exchange liquid chromatography (AEX). Moreover, a
fast and easy scale-up method from 4.6 mm id analytical to
preparative scale was successfully achieved using a 25 mm id
Agilent PL-SAX column, enabling higher sample loading and
helping you to meet your yield requirements using aqueous
buffer or nonvolatile conditions. Finally, PL-SAX is also
available as bulk resins, making them ideal for fractionating
large quantities of material.
References
1. Hsiao, J.; Apffel, A.; Turner, M. Optimizing Separation of
Oligonucleotides with Anion-Exchange Chromatography,
Agilent Technologies application note, 5994-4753EN,
2022.
2. Massi, J.; Lloyd, L. High Resolution Separations of
Oligonucleotides using PL-SAX Strong Anion-Exchange
HPLC Columns, Agilent Technologies application note,
5990-8297EN, 2021.
3. Tripodi, A. A. P.; Coffey, A. Superficially Porous Columns
for Semi-Preparative Purification of s Oligonucleotides,
Agilent Technologies application note, 5994-7478EN,
2024.